European Pharmaceutical Review

OCTOBER 27, 2022

The report’s authors identified that nearly 36 percent of biopharma companies will be increasing their spending on outsourced R&D or biomanufacturing over the next 12 months. Average budgets for outsourcing at individual facilities also remain relatively steady, growing by a weighted average increase of 12.8 percent in 2022.

Biopharma 80

Biopharma Manufacturing Pharmacology Training 80

Clarivate

DECEMBER 14, 2023

Here are a few trends in life sciences and healthcare our analysts are keeping an eye on – and what they expect to see in 2024: Move over, oncology – metabolic drugs are the new hotness: The successful launches of Novo Nordisk’s Wegovy® and Eli Lilly’s Mounjaro® represent a revolutionary pharmacological breakthrough of rare proportions.

Pharma 111

Pharma Pharmacology Government Healthcare 111

Clarivate

FEBRUARY 28, 2023

“A Hospital-Based Five-Year Prospective Study on the Prevalence of Leber’s Hereditary Optic Neuropathy with Genetic Confirmation.” Frontiers in Pharmacology; 13:1089033; DOI: 10.3389/fphar.2022.1089033 . “Leber Hereditary Optic Neuropathy: Case Report and Literature Review.” ” Cureus; V.12;

Prescription 98

Prescription Patients Pharmacology Healthcare 98